The Relationship Between Dipeptidyl Peptidase-4 Inhibitor Usage and Asymptomatic Amylase Lipase Increment in Type 2 Diabetes Mellitus Patients

Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2020, Vol 17, Issue 1

Abstract

Objectives: In different studies, it has been shown that the use of dipeptidyl peptidase-4 (DPP-4) inhibitors (DPP-4 inh) does not increase the risk of pancreatitis or pancreatic cancer. Although the number of studies involving clinical pancreatitis clinics is sufficient, the number of studies involving clinical non-pancreatitis hyperamylasemia is rare. The aim of the study was to investigate the relationship between DPP-4 inh usage and amylase and lipase increment without clinical pancreatitis symptoms. Materials and Methods: Eighty-seven patients who met the inclusion criteria were enrolled. The patients were divided into 3 groups according to their use of saxagliptin, sitagliptin, or vildagliptin. All patients included in the study were receiving metformin at a dose of 2 g/day. Fasting blood glucose, postprandial blood glucose, HbA1C, serum creatinine, ALT, amylase, and lipase results were recorded at the beginning of treatment and at the end of 3 months. Results: There was an increase in all groups in terms of amylase and lipase values but there was no significant difference between the groups in terms of increase (p>0.05) There was no statistically significant increase in the saxagliptin and vildagliptin groups (p>0.05) when the baseline and 3-month values of lipase and amylase increase were examined. However, there was a statistically significant increase in amylase and lipase in the sitagliptin group (p<0.05). Conclusion: The use of DPP-4 inh can increase amylase and lipase levels without clinical findings of acute pancreatitis in the patient. DPP-4 inh should be used with caution in patients at risk for pancreatitis and pancreatic cancer. Patients using DPP-4 inh, especially sitagliptin, should be evaluated carefully for pancreatitis risk factors.

Authors and Affiliations

Zeynel Abidin SAYİNER, Gamze İNAN DEMİROĞLU, Ersin AKARSU, Mustafa ARAZ

Keywords

Related Articles

Various In Vitro Bioactivities of Secondary Metabolites Isolated from the Sponge Hyrtios aff. Erectus from the Red Sea Coast of Egypt

Objectives: The present study revealed the presence of bioactive constituents in Hyrtios aff. erectus sponge (HES) extract collected from the Red Sea using skin and scuba diving. Materials and Methods: Cytotoxicity was...

Evaluation of Antiinflammatory Activity of Ethanol Extract of Nelumbo nucifera Fruit

Objectives: In recent times, the use of natural remedies, which are rich in varieties of vitamins and flavonoids, for treatment of inflammation has increased substantially. These natural remedies are expected to be safe...

Safety Assessment of Vanillic Acid: Subacute Oral Toxicity Studies in Wistar Rats

Objectives: Vanillic acid (VA) is a flavoring agent, a phenolic acid, and an intermediary by-product formed during transformation of ferulic acid to vanillin. It has been investigated for diverse pharmacological actions...

Two New Factors for the Evaluation of Scientific Performance: U and U’

Scientific performance of researchers that translates into academic improvement, tenure position in universities and project grants are commonly evaluated by using some bibliometric indicators. These indicators can be ca...

Investigation of the Polyphenol Composition, Biological Activities, and Detoxification Properties of Some Medicinal Mushrooms from Turkey

Objectives: Ethanolic extracts of the mushroom species Ganoderma adspersum, Inonotus hispidus, Russula chloroides, and Sarcodon imbricatus were investigated for their polyphenolic contents and biological activities. Mat...

Download PDF file
  • EP ID EP684732
  • DOI 10.4274/tjps.galenos.2018.83788
  • Views 161
  • Downloads 0

How To Cite

Zeynel Abidin SAYİNER, Gamze İNAN DEMİROĞLU, Ersin AKARSU, Mustafa ARAZ (2020). The Relationship Between Dipeptidyl Peptidase-4 Inhibitor Usage and Asymptomatic Amylase Lipase Increment in Type 2 Diabetes Mellitus Patients. Turkish Journal of Pharmaceutical Sciences, 17(1), -. https://europub.co.uk/articles/-A-684732